Article
Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation.
Pharmacogenetics and genomics - 1 Oct 2012
Menon Saras, Lea Rod A, Roy Bishakha, Hanna Michelle, Wee Shirley, Haupt Larisa M, Oliver Chris, Griffiths Lyn R
Abstract excerpt
BACKGROUND: Migraine is a chronic disabling neurovascular condition that may in part be caused by endothelial and cerebrovascular disruption induced by hyperhomocysteinaemia. We have previously provided evidence indicating that reduction of homocysteine by vitamin supplementation can reduce the occurrence of migraine in women. The current study examined the genotypic effects of methylenetetrahydrofolate reductase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
